Ectopic ERK expression induces phenotypic conversion of C10 cells and alters DNA methyltransferase expression.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 3416577)

Published in BMC Res Notes on May 04, 2012

Authors

Ryan L Sontag1, Thomas J Weber

Author Affiliations

1: Systems Toxicology, Pacific Northwest National Laboratory, 790 6th Street, J4-02, Richland, WA 99354, USA.

Articles cited by this

Genetic instabilities in human cancers. Nature (1998) 22.76

Perceptions of epigenetics. Nature (2007) 8.43

Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J Cell Biol (1993) 4.24

Efficient screening of retroviral cDNA expression libraries. Proc Natl Acad Sci U S A (1995) 2.46

The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther (2005) 2.10

Non-targeted and delayed effects of exposure to ionizing radiation: II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiat Res (2003) 2.10

Expression and modulation of an NADPH oxidase in mammalian astrocytes. J Neurosci (2005) 1.71

Epigenetic alterations are critical for fear memory consolidation and synaptic plasticity in the lateral amygdala. PLoS One (2011) 1.58

Persistent oxidative stress in chromosomally unstable cells. Cancer Res (2003) 1.53

Mouse lung epithelial cell lines--tools for the study of differentiation and the neoplastic phenotype. Toxicology (1997) 1.49

Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-PI3K-Akt/ERK MAP kinase signaling in pulmonary epithelial cells. Antioxid Redox Signal (2006) 1.44

Inhaled particulate matter causes expression of nuclear factor (NF)-kappaB-related genes and oxidant-dependent NF-kappaB activation in vitro. Am J Respir Cell Mol Biol (2000) 1.32

Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors. Blood (2004) 1.28

Different accumulation of activated extracellular signal-regulated kinases (ERK 1/2) and role in cell-cycle alterations by epidermal growth factor, hydrogen peroxide, or asbestos in pulmonary epithelial cells. Am J Respir Cell Mol Biol (2001) 1.27

Mek1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells. J Biol Chem (1996) 1.21

Procainamide inhibits DNA methyltransferase in a human T cell line. J Rheumatol (1991) 1.12

DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation system. Biochem Biophys Res Commun (2004) 1.11

Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy. Curr Genomics (2009) 1.11

AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model. Environ Health Perspect (2002) 1.07

Role of the ras-MAPK signaling pathway in the DNA methyltransferase response to DNA hypomethylation. Biol Chem (1998) 1.07

Effects of active MEK1 expression in vivo. Cancer Lett (2005) 1.05

MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals. Mol Cancer Ther (2011) 1.05

Dual role of MEK/ERK signaling in senescence and transformation of intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2003) 1.01

Nicotine, lung and cancer. Anticancer Agents Med Chem (2007) 0.97

RhoA influences the nuclear localization of extracellular signal-regulated kinases to modulate p21Waf/Cip1 expression. Circulation (2003) 0.94

Transfection of constitutively active mitogen-activated protein/extracellular signal-regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells. Cancer Res (2000) 0.94

Increased localization and substrate activation of protein kinase C delta in lung epithelial cells following exposure to asbestos. Am J Pathol (2002) 0.93

Molecular regulation of NADPH oxidase 5 via the MAPK pathway. Am J Physiol Heart Circ Physiol (2011) 0.93

Transcriptional regulation of basal cyclooxygenase-2 expression in murine lung tumor-derived cell lines by CCAAT/enhancer-binding protein and activating transcription factor/cAMP response element-binding protein. Mol Pharmacol (2002) 0.90

Constitutive MAP kinase activation in hematopoietic stem cells induces a myeloproliferative disorder. PLoS One (2011) 0.87

Basic fibroblast growth factor regulates persistent ERK oscillations in premalignant but not malignant JB6 cells. J Invest Dermatol (2009) 0.85

Development and characterization of type 2 pneumocyte-related cell lines from normal adult mouse lung. Pathology (1984) 0.84

Modulation of JB6 mouse epidermal cell transformation response by the prostaglandin F2alpha receptor. Mol Carcinog (2002) 0.80

PGE2-mediated cytoprotection in renal epithelial cells: evidence for a pharmacologically distinct receptor. Am J Physiol (1997) 0.80

Articles by these authors

Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. J Clin Invest (2014) 1.24

AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model. Environ Health Perspect (2002) 1.07

New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men. J Clin Endocrinol Metab (2004) 0.97

Cost-effectiveness of oral bisphosphonates for osteoporosis at different ages and levels of life expectancy. J Am Geriatr Soc (2011) 0.87

Fractures in children with Pompe disease: a potential long-term complication. Pediatr Radiol (2007) 0.87

Network analysis of epidermal growth factor signaling using integrated genomic, proteomic and phosphorylation data. PLoS One (2012) 0.87

Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate. Radiat Res (2012) 0.87

Older men's explanatory model for osteoporosis. Gerontologist (2011) 0.84

Hypovitaminosis D in glycogen storage disease type I. Mol Genet Metab (2009) 0.81

In situ live cell sensing of multiple nucleotides exploiting DNA/RNA aptamers and graphene oxide nanosheets. Anal Chem (2013) 0.80

Tumor-induced osteomalacia masking primary hyperparathyroidism. Surgery (2012) 0.79

Deficient expression of aldehyde dehydrogenase 1A1 is consistent with increased sensitivity of Gorlin syndrome patients to radiation carcinogenesis. Mol Carcinog (2013) 0.79

Inhibition of ERK oscillations by ionizing radiation and reactive oxygen species. Mol Carcinog (2010) 0.78

Cellular dichotomy between anchorage-independent growth responses to bFGF and TPA reflects molecular switch in commitment to carcinogenesis. Mol Carcinog (2009) 0.78

ERK oscillation-dependent gene expression patterns and deregulation by stress response. Chem Res Toxicol (2014) 0.78

Reactive oxygen species alter autocrine and paracrine signaling. Free Radic Biol Med (2011) 0.78

Fourier-transform infrared spectroscopy for rapid screening and live-cell monitoring: application to nanotoxicology. Nanomedicine (Lond) (2013) 0.77

Hepatic leukemia factor promotes resistance to cell death: implications for therapeutics and chronotherapy. Toxicol Appl Pharmacol (2013) 0.76

Battle of the sex steroids in the male skeleton: and the winner is…. J Clin Invest (2016) 0.75

Following the forgotten phosphorus. Am J Med (2009) 0.75

Disorders of phosphorus homeostasis. Curr Opin Endocrinol Diabetes Obes (2010) 0.75

EMPLOYEE EMBEZZLEMENT. Pa Dent J (Harrisb) (2016) 0.75

$100 special assessment approved. Pa Dent J (Harrisb) (2003) 0.75

Protecting your office from employee theft. Pa Dent J (Harrisb) (2003) 0.75

HIPAA privacy compliance deadline quickly approaching. Pa Dent J (Harrisb) (2003) 0.75

Physiologically based pharmacokinetic modeling of 1,4-Dioxane in rats, mice, and humans. Toxicol Sci (2007) 0.75

Maintaining compliance in a 21st century dental practice: electronic communications and HIPAA compliance. Pa Dent J (Harrisb) (2013) 0.75

Obtaining payment for treatment of children of divorce. Pa Dent J (Harrisb) (2003) 0.75

To report or not to report. Pa Dent J (Harrisb) (2003) 0.75

Ten trouble spots that can put you (and potentially your license) in hot water. Pa Dent J (Harrisb) (2014) 0.75

Using imaging methods to interrogate radiation-induced cell signaling. Radiat Res (2012) 0.75

Treating the minor patient. Pa Dent J (Harrisb) (2002) 0.75